Neuphoria Therapeutics (NEUP) vs Rocket One (RKTO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Rocket One (RKTO) has outperformed Neuphoria Therapeutics (NEUP) over the past year, losing 61.1% versus a loss of 82.3%. Neuphoria Therapeutics is the larger company by market cap ($18.2 million vs $16.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NEUP | RKTO |
|---|---|---|
| Share price | $3.36 | $0.6493 |
| Market cap | $18.18M | $16.17M |
| 1-day change | +0.30% | +0.50% |
| YTD return | -13.40% | -34.41% |
| 1-year return | -82.32% | -61.12% |
| 5-year return | — | -97.76% |
| EPS (TTM) | $-3.05 | $-0.83 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $18.39 | $2.45 |
| 52-week low | $3.19 | $0.489 |
| Distance from 52-week high | -81.73% | -73.50% |
| Analyst consensus | none | — |
| Average volume | 164.07K | 554.01K |
| Shares outstanding | 5.41M | 24.90M |
| Employees | 1 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RKTO has outperformed NEUP by 21.2 percentage points over the past year.
About Neuphoria Therapeutics
NEUP stock →Neuphoria Therapeutics Inc., a clinical stage biopharmaceutical company, develops novel allosteric ion channel modulators for patients with serious central nervous system disorders in Australia. Its lead product candidate is BNC210, an oral, proprietary, selective negative allosteric modulator of the alpha7 nicotinic acetylcholine receptor for post-traumatic stress disorder.
Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees
About Rocket One
RKTO stock →Rocket One Inc. focuses on developing and commercializing AI semiconductor infrastructure.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
NEUP vs RKTO FAQ
Which is bigger, Neuphoria Therapeutics or Rocket One?
Neuphoria Therapeutics (NEUP) is larger, with a market capitalization of $18.18M compared with $16.17M for Rocket One (RKTO).
Which stock has performed better over the past year, NEUP or RKTO?
RKTO returned -61.12% over the past 12 months, compared with -82.32% for NEUP (price return, excluding dividends). Past performance does not predict future results.
Are Neuphoria Therapeutics and Rocket One in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.